Wei Zhang
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma Hepatocellular Carcinoma (HCC) | Phase 2 | 2025-12-30 |
| Unknown | Efficacy and Safety of Regorafenib Maintenance Therapy in Patients With Metastatic Colorectal Cancer (mCRC) Colorectal Cancer | N/A | 2023-06-26 |